The cost of psoriasis.
Crown discussed findings of a Medstat study probing the economic burden of psoriasis and the presence of comorbidity in psoriasis patients. He also discussed current economic issues in the marketplace, concluding with some thoughts on health economics and biologics--which are shifting the landscape of pharmacotherapy.
Outcomes Research and Econometrics, The Medstat Group, Ann Arbor, Mich, USA.
William H
WH
Crown
D015535:Arthritis, Psoriatic / Q000188:drug therapy; D015897:Comorbidity; D017281:Cost of Illness; D003362:Cost-Benefit Analysis; D016527:Drug Costs / Q000706:statistics & numerical data*; D004358:Drug Therapy / Q000191:economics; D006801:Humans; D007155:Immunologic Factors / Q000191:economics; D007345:Insurance Claim Review; D019458:Insurance Coverage / Q000191:economics* / Q000706:statistics & numerical data; D010789:Phototherapy / Q000191:economics; D011362:Professional Corporations; D011565:Psoriasis / Q000188:drug therapy / Q000191:economics* / Q000453:epidemiology
D007155:Immunologic Factors